Gabriel Morris - Dec 20, 2021 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Chief Financial Officer, Director
Signature
/s/ Gabriel S Morris
Stock symbol
IMMX
Transactions as of
Dec 20, 2021
Transactions value $
$22,696
Form type
4
Date filed
12/20/2021, 03:15 PM
Previous filing
Dec 15, 2021
Next filing
Jul 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Conversion of derivative security $63K +74.1K $0.85 74.1K Dec 20, 2021 Direct
transaction IMMX Common Stock Conversion of derivative security $105K +124K $0.85 124K Dec 20, 2021 See footnote F3
transaction IMMX Common Stock Conversion of derivative security $105K +123K +99.72% $0.85 247K Dec 20, 2021 See footnote F3
transaction IMMX Common Stock Purchase $10K +2K +2.7% $5.00 76.1K Dec 20, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Convertible Note Conversion of derivative security -$60K 0 Dec 20, 2021 Common stock 74.1K $0.85 Direct F1
transaction IMMX Convertible Note Conversion of derivative security -$100K 0 Dec 20, 2021 Common stock 124K $0.85 See footnote F2, F3
transaction IMMX Convertible Note Conversion of derivative security -$100K 0 Dec 20, 2021 Common stock 123K $0.85 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 18, 2021, the Registrant issued the Reporting Person a note in the amount of $60,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
F2 On March 18, 2021, the Registrant issued Alwaysraise LLC a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
F3 Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity.
F4 On April 2, 2021, the Registrant issued Alwaysraise a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.